Philippe J Guerin

TL;DR: While the advent of conjugate A vaccine is anticipated to largely contribute to control serogroup A outbreaks in Africa, the scale-up of its production will not cover the entire “Meningitis Belt” target population for at least the next 3 to 5 years.

TL;DR: Five recommendations are formulated to help achieve a balance between early access to research findings and its negative consequences, and high level consultations should be convened to formulate clear principles and policies for the publication and dissemination of non-peer reviewed research results.

TL;DR: Evidence is provided that health system performance, drug quality and patient adherence influence the effectiveness of anti-malarials used in treating uncomplicated falciparum malaria, and this study provides guidance to countries’ treatment practises.

TL;DR: Clinical trial guidelines should include a requirement to assess and state the quality of the drugs and other medical products used, Paul Newton and colleagues propose.

TL;DR: It is suggested that treatment outcomes depend on the programme's capacity to respond to specific patients' constraints, and high-risk groups, such as migrant populations, need a patient-centred approach, and specific, innovative strategies have to be developed based on the needs of the most vulnerable and marginalised populations.